Find clinical trials for Ovarian Cancer in Chicago, IL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Ovarian Cancer trials near Chicago, IL, USA:
This study is being done to answer the following question: What are the effects of a new drug or drugs on ovarian cancer? The pre-s...
Phase 2
Chicago, Illinois, United States and 6 other locations
and further the remissions and duration of remissions with standard ovarian cancer chemotherapy with carboplatin and paclitaxel. As...
Phase 2
Maywood, Illinois, United States
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Hinsdale, Illinois, United States and 213 other locations
of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...
Phase 3
Evanston, Illinois, United States and 125 other locations
efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian...
Phase 2
Hinsdale, Illinois, United States and 20 other locations
mirvetuximab soravtansine (MIRV) in patients with platinum resistant ovarian cancer. Approximately 102 patients will be enrolled in...
Phase 1
Chicago, Illinois, United States and 20 other locations
the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...
Phase 2
Chicago, Illinois, United States and 46 other locations
This is a multi-center, open-label phase 1 dose escalation trial that uses a modified 3+3 design to identify a recommended phase 2 dose (RP2D) of AB-...
Phase 1
Chicago, Illinois, United States and 9 other locations
positive, recurrent platinum sensitive, high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancer following 1 pri...
Phase 2
Chicago, Illinois, United States and 70 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Chicago, Illinois, United States and 176 other locations
Clinical trials
Research sites
Resources
Legal